13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0002111611
Total reported value
$161.4M
$161.4M
14 檔
60.5%
At the close of Q1 2026, Buckley Capital Advisors, LLC disclosed equity holdings valued at approximately $161.4M, spread across 14 reported holdings.
In Q1 2026, Buckley Capital Advisors, LLC displayed an active expansion posture, initiating 3 new positions and adding to 6 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LQDA | Liquidia CORP | Stock-Other | 32.10% | -11.45% | -4.28% | |
| 2 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 11.18% | -11.18% | EXIT | |
| 3 | SGHC | Super Group (SGHC) Limited | Stock-Other | 10.04% | +2.54% | +35.15% | |
| 4 | DAVE | Dave Inc | Stock-Other | 9.59% | +3.61% | +22.65% | |
| 5 | PRTH | Priority Technology Holdings | Stock-Other | 7.25% | +1.39% | +19.43% | |
| 6 | ROOT | Root Inc/oh -class A | Stock-Other | 5.54% | -5.54% | EXIT | |
| 7 | WLFC | Willis Lease Finance CORP | Stock-Other | 4.80% | +1.71% | -54.65% | |
| 8 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 4.37% | -4.37% | EXIT | |
| 9 | ✓ | Establishment Labs Holdings In | Stock-Other | 3.84% | -2.51% | -50.00% | |
| 10 | HGV | Hilton Grand Vacations Inc | Stock-Other | 3.56% | +4.21% | +2.09% | |
| 11 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 3.37% | -3.37% | EXIT | |
| 12 | SEZL | Sezzle Inc | Stock-Other | 2.84% | -2.84% | EXIT | |
| 13 | FLYW | Flywire Corp-voting | Stock-Other | 0.98% | +2.22% | — | |
| 14 | BVS | Bioventus Inc - A | Stock-Other | 0.54% | -0.20% | -79.79% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LQDA | Liquidia CORP | +2.1% | -4.28% | Trim |
| 2 | SGHC | Super Group (SGHC) Limited | +2% | +35.15% | Add |
| 3 | PRTH | Priority Technology Holdings | +0.4% | +19.43% | Add |
| 4 | ROOT | Root Inc/oh -class A | -0.1% | +58.37% | Add |
| 5 | DAVE | Dave Inc | -0.2% | +22.65% | Add |
| 6 | HGV | Hilton Grand Vacations Inc | -0.4% | +2.09% | Add |
| 7 | SLNOEUR | Soleno Therapeutics Inc | -0.5% | +21.86% | Add |
| 8 | MLYS | Mineralys Therapeutics Inc | -1.1% | -0.69% | Trim |
| 9 | BVS | Bioventus Inc - A | -1.6% | -79.79% | Trim |
| 10 | WLFC | Willis Lease Finance CORP | -3.5% | -54.65% | Trim |
| 11 | ✓ | Establishment Labs Holdings In | -5.8% | -50.00% | Trim |
| 12 | ACHC | Acadia Healthcare Co Inc | — | NEW | New buy |
| 13 | EOLS | Evolus Inc | — | EXIT | Sold out |
| 14 | GOGO | Gogo Inc | — | EXIT | Sold out |
| 15 | SEZL | Sezzle Inc | — | NEW | New buy |
| 16 | FLYW | Flywire Corp-voting | — | NEW | New buy |
According to official SEC Form 13F filings, Buckley Capital Advisors, LLC reported a total U.S. public equity portfolio value of $161.4M across 14 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including LQDA, ACHC, SGHC) accounted for 60.5% of total reported equity market value during Q1 2026.
Top New Position Initiated
ACHC
市值: $15.6M
Top Position Liquidated / Trimmed
EOLS
前期市值: $4.9M
During Q1 2026, Buckley Capital Advisors, LLC's top holdings by market value included LQDA (32.1%)、ACHC (11.2%)、SGHC (10.0%). The largest single position, LQDA, represented 32.1% of total portfolio value.
In Q1 2026, Buckley Capital Advisors, LLC made 16 total portfolio adjustments, initiating 3 new buys, adding to 6 positions, trimming 5 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.